Montaner LJ - Search Results

1

The Natural Stilbenoid (-)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants.

Tietjen I, Cassel J, Register ET, Zhou XY, Messick TE, Keeney F, Lu LD, Beattie KD, Rali T, Tebas P, Ertl HCJ, Salvino JM, Davis RA, Montaner LJ. Tietjen I, et al. Among authors: montaner lj. Antimicrob Agents Chemother. 2021 Nov 17;65(12):e0077221. doi: 10.1128/AAC.00772-21. Epub 2021 Sep 20. Antimicrob Agents Chemother. 2021. PMID: 34543092 Free PMC article.

2

Antiretroviral therapy interruptions result in loss of protective humoral immunity to neoantigens in HIV-infected individuals.

Azzoni L, Foulkes AS, Firnhaber C, Yin X, Xiang ZQ, Li Y, Stevens W, Gross R, Ertl HC, Sanne I, Montaner LJ. Azzoni L, et al. Among authors: montaner lj. AIDS. 2012 Jul 17;26(11):1355-62. doi: 10.1097/QAD.0b013e328354648e. AIDS. 2012. PMID: 22516873 Free PMC article. Clinical Trial.

3

Improved treatment for primary HIV infection by interferon-alfa therapy? Does HCV treatment in HIV/HCV coinfected patients help us to test this hypothesis? Reply to zur Wiesch and van Lunzen.

Azzoni L, Foulkes AS, Papasavvas E, Mexas AM, Lynn KM, Mounzer K, Tebas P, Jacobson JM, Frank I, O'Doherty U, Kostman J, Montaner LJ. Azzoni L, et al. Among authors: montaner lj. J Infect Dis. 2013 Jul 15;208(2):363. doi: 10.1093/infdis/jit160. Epub 2013 Apr 9. J Infect Dis. 2013. PMID: 23570845 No abstract available.

4

IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.

Tomescu C, Tebas P, Montaner LJ. Tomescu C, et al. Among authors: montaner lj. AIDS. 2017 Mar 13;31(5):613-622. doi: 10.1097/QAD.0000000000001380. AIDS. 2017. PMID: 28225449 Free PMC article.

5

BCL6 BTB-specific inhibition via FX1 treatment reduces Tfh cells and reverses lymphoid follicle hyperplasia in Indian rhesus macaque (Macaca mulatta).

Cai Y, Watkins MA, Xue F, Ai Y, Cheng H, Midkiff CC, Wang X, Alvarez X, Poli ANR, Salvino JM, Veazey RS, Montaner LJ. Cai Y, et al. Among authors: montaner lj. J Med Primatol. 2020 Feb;49(1):26-33. doi: 10.1111/jmp.12438. Epub 2019 Oct 1. J Med Primatol. 2020. PMID: 31571234 Free PMC article.

6

Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals.

Yadav A, Kossenkov AV, Knecht VR, Showe LC, Ratcliffe SJ, Montaner LJ, Tebas P, Collman RG. Yadav A, et al. Among authors: montaner lj. Pathog Immun. 2019 Dec 17;4(2):324-362. doi: 10.20411/pai.v4i2.336. eCollection 2019. Pathog Immun. 2019. PMID: 31893252 Free PMC article.

7

Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH.

Tomescu C, Kroll K, Colon K, Papasavvas E, Frank I, Tebas P, Mounzer K, Reeves RK, Montaner LJ. Tomescu C, et al. Among authors: montaner lj. Eur J Immunol. 2021 Aug;51(8):2051-2061. doi: 10.1002/eji.202149188. Epub 2021 Jun 19. Eur J Immunol. 2021. PMID: 34086344 Free PMC article.

8

BCL6 BTB-specific inhibitor reversely represses T-cell activation, Tfh cells differentiation, and germinal center reaction in vivo.

Cai Y, Poli ANR, Vadrevu S, Gyampoh K, Hart C, Ross B, Fair M, Xue F, Salvino JM, Montaner LJ. Cai Y, et al. Among authors: montaner lj. Eur J Immunol. 2021 Oct;51(10):2441-2451. doi: 10.1002/eji.202049150. Epub 2021 Sep 16. Eur J Immunol. 2021. PMID: 34287839 Free PMC article.

9

Design, synthesis and screening of a drug discovery library based on an Eremophila-derived serrulatane scaffold.

Zhang C, Lum KY, Taki AC, Gasser RB, Byrne JJ, Wang T, Blaskovich MAT, Register ET, Montaner LJ, Tietjen I, Davis RA. Zhang C, et al. Among authors: montaner lj. Phytochemistry. 2021 Oct;190:112887. doi: 10.1016/j.phytochem.2021.112887. Epub 2021 Jul 30. Phytochemistry. 2021. PMID: 34339980

10

Lack of Atorvastatin Effect on Monocyte Gene Expression and Inflammatory Markers in HIV-1-infected ART-suppressed Individuals at Risk of non-AIDS Comorbidities.

Yadav A, Kossenkov AV, Showe LC, Ratcliffe SJ, Choi GH, Montaner LJ, Tebas P, Shaw PA, Collman RG. Yadav A, et al. Among authors: montaner lj. Pathog Immun. 2021 Aug 13;6(2):1-26. doi: 10.20411/pai.v6i2.461. eCollection 2021. Pathog Immun. 2021. PMID: 34447895 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

207 results

Search Page